Publicado em Negócios

Subunit Vaccines Market Research (2017-2022) Report by Growth Rate, Trends and Opportunities

por em12 Fevereiro 2018 33 acessos
  • .
Report ThisConteúdo Inadequado? Avise-nos

Subunit Vaccines Market Research Report (2017-2022) Provides In-Depth Analysis by Scope, Growth Rate, Driving Factors, Competitive Situation, Top Manufacturers and Upcoming Trends. Subunit Vaccines Market report split global into several key Regions which mainly includes Market Overview, Table of Content, List of Figures and Applications. Subunit Vaccines Market Growing at Higher CAGR Rate of XX% between (2017-2022).


The global Subunit Vaccines market is classified on the basis of type, product type, indications, application and geography. A vaccine is a biological preparation that delivers active acquired immunity to a specific disease. A vaccine usually contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to identify the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

View Full Table of Contents of This Report @


Top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering   

    • Astellas Pharma Inc

    •  CSL Limited

    • Emergent BioSolutions, Inc

    • GlaxoSmithKline

    • Other

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into   

    • Pneumococcal

    • Influenza

    • Other

Split by application, this report focuses on sales, market share and growth rate of Subunit Vaccines in each application, can be divided into

    • Pediatric

    • Adult

    • Other

There are different types of vaccines such as inactivated, toxoid, attenuated, subunit, conjugate, and so on. Subunit vaccines are vaccines that use only part of the disease-causing virus.Subunit vaccines, like inactivated whole-cell vaccines, do not contain live components of the pathogen. They differ from inactivated whole-cell vaccines, by containing only the antigenic parts of the pathogen. These parts are necessary to elicit a protective immune response.

The factors that propel the global growth include long-lived immunity provided by this vaccine and risk of reactions are very low. In addition, subunit vaccines can be given to people with weakened immune systems. On the other hand, there are also factors that hamper the growth of the market such as numerous doses are required for proper life-long immunity.

On the basis of type, the market research report is classified as protein-based subunit vaccines, polysaccharide vaccine and conjugate subunit vaccine. Protein based subunit vaccines present an antigen to the immune system without viral particles, using a specific, isolated protein of the pathogen. Commonly used protein-based subunit vaccines are acellular pertussis (aP) vaccines and Hepatitis B.

Some bacteria when infecting humans are often protected by a polysaccharide (sugar) capsule that helps the organism evade the human defence systems especially in infants and young children. Polysaccharide vaccines create a response against the molecules in the pathogen's capsule. These molecules are small, and often not very immunogenic.Examples of polysaccharide vaccines include Meningococcal disease caused by Neisseria meningitidis groups A, C, W135 and Y, as well as Pneumococcal disease.

Conjugate subunit vaccines also create a response against the molecules in the pathogen's capsule. In comparison to plain polysaccharide vaccines, they benefit from a technology that binds the polysaccharide to a carrier protein Carrier protein A, a protein linked to a weak antigen to increase its immunogenicity when used as a vaccine that can induce a long-term protective response even in infants.


Request a Sample PDF Copy of This Report @

Table of Contents:-

  • Subunit Vaccines Market Overview
  • Subunit Vaccines Market Competition by Manufacturers
  • Subunit Vaccines Market Production, Revenue (Value) by Region (2012-2017)
  • Subunit Vaccines Market Supply (Production), Consumption, Export, Import by Regions (2012-2017)
  • Subunit Vaccines Market Production, Revenue (Value), Price Trend by Type
  • Subunit Vaccines Market Analysis by Application
  • Subunit Vaccines Market Manufacturers Profiles/Analysis
  • Subunit Vaccines Market Manufacturing Cost Analysis
  • Subunit Vaccines Market Industrial Chain, Sourcing Strategy and Downstream Buyers
  • Subunit Vaccines Market Marketing Strategy Analysis, Distributors/Traders
  • Subunit Vaccines Market Effect Factors Analysis
  • Subunit Vaccines Market Research Findings and Conclusion

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo.

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

tel: 91-20-65300184

Email: Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo.

Visit Our Blog:

Última modificação em 12 Fevereiro 2018

Web Marketing Executive